This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://digital.ahrq.gov/contact-us. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to digital.ahrq.gov for current information.

The role of mobile phones in improving vaccination rates in travelers

Authors
Vilella, A., Bayas, J. M., Diaz, M. T., Guinovart, C., Diez, C., Simo, D., Munoz, A., Cerezo, J.
Journal
Prev Med
Publication Date
2004 Apr
Volume
38
Issue
4
Pages
503-9
  • HIT Description: short message service (SMS) text reminders regarding vaccinations More info...
  • Purpose of Study: assess whether text messaging by mobile phone with computer-generated reminders regarding the data of the next vaccine dose would lead to increased compliance with hepatitis A and B vaccine schedules
  • Years of study: 2001
  • Study Design: controlled clinical trial
  • Outcomes: impact on health care effectiveness and quality
Summary:
  • Settings: travelers who attended the International-Clinic Vaccination Centre, a travel clinic in Spain
  • Intervention: travelers with mobile phones who agreed to participate and who were seen in two of the three offices within the Centre received pre-programmed messages regarding upcoming vaccination doses that were due. The control groups consisted of patients receiving the same vaccines from the third office over the same time period; and, subjects who had received the vaccines in the previous year.
  • Evaluation Method: chart review
  • Description: mobile phone number information was entered into a web page for processing by mBusiness platform (GlaxoSmithKline) which sends out pre-programmed messages at programmed times.
  • Quality of Care and Patient Safety Outcome: SMS text messaging appear to increase compliance with vaccination doses: for the second hepatitis A and B dose, compliance was 88.4% in the study group, and 80.7% and 77.2% in the two control groups, respectively. For the third vaccine doses, compliance was 47.1% in the study group compared to 26.9% and 23.6% in the control groups
The information on this page is archived and provided for reference purposes only.